Proportion of Ugandans with pre-pandemic SARS-CoV-2 cross-reactive CD4+ and CD8+ T-cell responses: A pilot study

• Annemarie Namuniina,

  Roles Data curation, Formal analysis, Investigation, Writing – original draft

  Affiliation UVRI-IAVI HIV Vaccine Program, Entebbe, Uganda

  ⨯
• Enoch S. Muyanja,

  Roles Data curation, Writing – review & editing

  Affiliation PATRU, School of Medicine, Emory University, Atlanta, Georgia, United States of America

  ⨯
• Victoria M. Biribawa,

  Roles Data curation, Writing – review & editing

  Affiliation UVRI-IAVI HIV Vaccine Program, Entebbe, Uganda

  ⨯
• Brenda A. Okech,

  Roles Supervision, Writing – review & editing

  Affiliation UVRI-IAVI HIV Vaccine Program, Entebbe, Uganda

  https://orcid.org/0000-0002-1722-5156

  ⨯
• Aloysious Ssemaganda,

  Roles Formal analysis, Writing – review & editing

  Affiliation Rady Faculty of Health Sciences, Department of Medical Microbiology and Infectious Diseases, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada

  https://orcid.org/0000-0003-4705-7912

  ⨯
• Matt A. Price,

  Roles Supervision, Writing – review & editing

  Affiliations IAVI, New York, New York, United States of America, Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Nancy Hills,

  Roles Formal analysis, Writing – review & editing

  Affiliations Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, United States of America, Department of Neurology, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Ann Nanteza,

  Roles Resources, Writing – review & editing

  Affiliation College of Veterinary Medicine, Animal Resources & Bio-security, Makerere University, Kampala, Uganda

  ⨯
• Bernard Ssentalo Bagaya,

  Roles Supervision, Writing – review & editing

  Affiliations Department of Immunology and Molecular Biology, College of Health Sciences, School of Biomedical Sciences, Makerere University, Kampala, Uganda, Integrated Biorepository of H3-Africa-Uganda (IBRH3AU), COVID-19 Biobank (COV-BANK), College of Health Sciences, Makerere University, Kampala, Uganda

  ⨯
• Daniela Weiskopf,

  Roles Conceptualization, Methodology, Resources, Writing – review & editing

  Affiliation Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, California, United States of America

  https://orcid.org/0000-0003-2968-7371

  ⨯
• Catherine Riou,

  Roles Formal analysis, Methodology, Visualization, Writing – review & editing

  Affiliations Department of Pathology, Division of Medical Virology, University of Cape Town, Cape Town, South Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa

  https://orcid.org/0000-0001-9679-0745

  ⨯
• Steven J. Reynolds,

  Roles Resources, Supervision, Writing – review & editing

  Affiliations Division of Intramural Research, NIAID, NIH, Baltimore Maryland, United States of America, Division of Infectious Diseases, Johns Hopkins School of Medicine, Baltimore, Maryland, United States of America, Rakai Health Sciences Program, Kalisizo, Uganda

  ⨯
• Ronald M. Galiwango,

  Roles Supervision, Writing – review & editing

  Affiliation Rakai Health Sciences Program, Kalisizo, Uganda

  ⨯
• Andrew D. Redd

  Roles Conceptualization, Formal analysis, Funding acquisition, Methodology, Project administration, Resources, Supervision, Writing – review & editing

  * E-mail: reddandrew@niaid.nih.gov

  Affiliations Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa, Division of Intramural Research, NIAID, NIH, Baltimore Maryland, United States of America, Division of Infectious Diseases, Johns Hopkins School of Medicine, Baltimore, Maryland, United States of America

  https://orcid.org/0000-0003-4651-1423

  ⨯